CA2595485A1 - Compositions liposomiques pour administration parenterale de statines - Google Patents

Compositions liposomiques pour administration parenterale de statines Download PDF

Info

Publication number
CA2595485A1
CA2595485A1 CA 2595485 CA2595485A CA2595485A1 CA 2595485 A1 CA2595485 A1 CA 2595485A1 CA 2595485 CA2595485 CA 2595485 CA 2595485 A CA2595485 A CA 2595485A CA 2595485 A1 CA2595485 A1 CA 2595485A1
Authority
CA
Canada
Prior art keywords
statin
liposome
micelle
composition
lipid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2595485
Other languages
English (en)
Inventor
Ellen Wasan
Marcel Bally
Sebastian Cogswell
Stuart Berger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
University Health Network
British Columbia Cancer Agency BCCA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University Health Network, British Columbia Cancer Agency BCCA filed Critical University Health Network
Priority to CA 2595485 priority Critical patent/CA2595485A1/fr
Publication of CA2595485A1 publication Critical patent/CA2595485A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2595485 2007-08-01 2007-08-01 Compositions liposomiques pour administration parenterale de statines Abandoned CA2595485A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2595485 CA2595485A1 (fr) 2007-08-01 2007-08-01 Compositions liposomiques pour administration parenterale de statines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2595485 CA2595485A1 (fr) 2007-08-01 2007-08-01 Compositions liposomiques pour administration parenterale de statines

Publications (1)

Publication Number Publication Date
CA2595485A1 true CA2595485A1 (fr) 2009-02-01

Family

ID=40339614

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2595485 Abandoned CA2595485A1 (fr) 2007-08-01 2007-08-01 Compositions liposomiques pour administration parenterale de statines

Country Status (1)

Country Link
CA (1) CA2595485A1 (fr)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104323997A (zh) * 2010-07-29 2015-02-04 湖南康都制药有限公司 辛伐他汀脂质体组合药物及其大工业化生产工艺和用途
WO2018045015A1 (fr) * 2016-09-01 2018-03-08 Kevin Jon Williams Procédés et kits pour réduire la tendance de particules de lipoprotéine à l'agrégation athérogène induite par des enzymes de paroi artérielle
EP3386503A4 (fr) * 2015-12-10 2019-08-07 Endoperfusion Solutions, LLC Méthodes et formulations pour le traitement d'une maladie vasculaire
US10709662B1 (en) 2020-01-29 2020-07-14 King Abdulaziz University Mucoadhesive buccal film having a dual release carrier system
CN114831938A (zh) * 2022-05-24 2022-08-02 郑州大学第一附属医院 一种包载阿托伐他汀钙的聚合物胶束、制剂及制备方法
CN115025242A (zh) * 2022-05-19 2022-09-09 南开大学 一种他汀前药和他汀靶向递送系统及其制备方法和应用

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104323997A (zh) * 2010-07-29 2015-02-04 湖南康都制药有限公司 辛伐他汀脂质体组合药物及其大工业化生产工艺和用途
EP3386503A4 (fr) * 2015-12-10 2019-08-07 Endoperfusion Solutions, LLC Méthodes et formulations pour le traitement d'une maladie vasculaire
WO2018045015A1 (fr) * 2016-09-01 2018-03-08 Kevin Jon Williams Procédés et kits pour réduire la tendance de particules de lipoprotéine à l'agrégation athérogène induite par des enzymes de paroi artérielle
CN109789217A (zh) * 2016-09-01 2019-05-21 凯文·乔恩·威廉姆斯 用于降低脂蛋白颗粒对动脉壁酶引起的致动脉粥样硬化性聚集的敏感度的方法和试剂盒
US10709662B1 (en) 2020-01-29 2020-07-14 King Abdulaziz University Mucoadhesive buccal film having a dual release carrier system
CN115025242A (zh) * 2022-05-19 2022-09-09 南开大学 一种他汀前药和他汀靶向递送系统及其制备方法和应用
CN115025242B (zh) * 2022-05-19 2023-10-20 南开大学 一种他汀前药和他汀靶向递送系统及其制备方法和应用
CN114831938A (zh) * 2022-05-24 2022-08-02 郑州大学第一附属医院 一种包载阿托伐他汀钙的聚合物胶束、制剂及制备方法

Similar Documents

Publication Publication Date Title
US10959951B2 (en) Pharmaceutical compositions for intraarticular delivery
US20080026049A1 (en) Liposomal compositions for parenteral delivery of agents
US20190151243A1 (en) Composition of matter comprising liposomes embedded in a polymeric matrix and methods of using same
JPH10506395A (ja) 二層安定化成分及びプログラムできる融合性リポソームの形成のためへのそれらの使用
US20170258722A1 (en) Encapsulating liposomes
CA2595485A1 (fr) Compositions liposomiques pour administration parenterale de statines
EP1448165B1 (fr) Compositions a vecteurs lipidiques et procedes garantissant une meilleure retention medicamenteuse
EA018246B1 (ru) Везикулярные составы, содержащие производные органических кислот, и процесс их приготовления
JP2010518012A (ja) カンプトテシン誘導体を含む医薬組成物
EP1399191A2 (fr) Agent therapeutique de penetration cellulaire
WO2006086992A2 (fr) Systemes d'apport de medicament contenant des derives de promedicament lipidique degradant la phospholipase a2 et utilisations therapeutiques de ces derniers par exemple en tant qu'agents de guerison des blessures ou en tant que ligands de recepteurs actives par un proliferateur au peroxysome
Matole et al. Need of liposomes as a novel drug delivery system
EP3986380A1 (fr) Formulation liposomale de doxorubicine, procédé de production d'une formulation liposomale de doxorubicine et utilisation d'une formulation liposomale de doxorubicine en tant que médicament
JP3693209B2 (ja) 閉鎖小胞の製造方法
US20230285293A1 (en) Pharmaceutical composition of intra-articular corticosteroid for pain control
WO2003022250A2 (fr) Vesicules stabilisees au moyen de polymeres hydrophiles a chaine courte

Legal Events

Date Code Title Description
FZDE Dead